Overview

Pioglitazone Protects Diabetes Mellitus (DM) Patients Against Re-Infarction (PPAR Study)

Status:
Terminated
Trial end date:
2018-04-01
Target enrollment:
Participant gender:
Summary
To evaluate whether the pioglitazone could reduce the recurrence of myocardial infarction (MI) in patients with DM and old myocardial infarction
Phase:
Phase 4
Details
Lead Sponsor:
National Cerebral and Cardiovascular Center
Collaborator:
Japan Heart Foundation
Treatments:
Pioglitazone